Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2003
10/28/2003US6638533 Pulse dosage formulations of methylphenidate and method to prepare same
10/28/2003US6638532 Tetracycline—doxycycline antibiotic composition
10/28/2003US6638531 Peptide antibiotics for resistant bacteria; fungicides
10/28/2003US6638530 N-(2-anilino)- and pyridino- substituents; mixed with polyoxyethylene glycol and surfactant, mineral acid salt of amino acid or propylene carbonate; absorbability; anticarcinogenic agents, immunosuppressants
10/28/2003US6638529 Lipid copound for use in the transfer macromolecules in cells
10/28/2003US6638528 Compositions and methods to effect the release profile in the transdermal administration of active agents
10/28/2003US6638524 Cosmetics, foods and beverages supplemented with purified strictinin
10/28/2003US6638522 Carrier comprising solubilizing amount of propylene glycol monoester of C6-C18 fatty acid and nonionic surfactant
10/28/2003US6638521 Oral liquid mucoadhesive compositions
10/28/2003US6638495 Stabilized preparation for use in metered dose inhalers
10/28/2003US6638494 Iron hydroxide, ferric hydrate, iron oxide, iron mixed oxide or iron; di- or polycarboxylic acid stabilizer; aggregation prevention; antitumor and contrast agents; immune boosters, magnetic resonance imaging, cell fusion, gene transfer
10/28/2003US6638270 Medical dressing assembly and associated method of using the same
10/28/2003US6638044 Apparatus for forming composite pellets for the controlled release of the active ingredient in the treatment of humans or animals
10/28/2003US6637437 Cell-culture and polymer constructs
10/28/2003CA2342309C New solid dose form of nanoparticulate naproxen
10/28/2003CA2263297C Inhibiting undesirable taste in oral compositions
10/28/2003CA2257890C Liquisolid systems and methods of preparing same
10/28/2003CA2241032C Blended pressure-sensitive adhesives
10/28/2003CA2209711C Plaster containing estradiol
10/28/2003CA2155085C The preparation of colloidal aqueous solutions of active substances of low solubility
10/28/2003CA2139505C Precipitation of one or more active compounds in situ
10/28/2003CA2137265C Palatable pharmaceutical compositions
10/28/2003CA2103487C Delayed-release form for pharmaceutical active compounds
10/28/2003CA2098667C The production of solid pharmaceutical depot forms
10/28/2003CA2073353C Glycerol-derived non ionic amphiphilic compounds, a process for their preparation, corresponding intermediary compounds and compositions containing said compounds
10/23/2003WO2003087444A1 Polymeric fibre and method for making same
10/23/2003WO2003087411A1 Method to inhibit cell growth using oligonucleotides
10/23/2003WO2003087389A2 Biologic modulations with nanoparticles
10/23/2003WO2003087344A1 New strains capable of producing conjugated linoleic acid, capsulated composition comprising them, and the preparation methods thereof
10/23/2003WO2003087339A2 Spray freeze dry of compositions for pulmonary administration
10/23/2003WO2003087335A2 Preservation of bioactive materials by spray drying
10/23/2003WO2003087327A2 Preservation of bioactive materials by freeze dried foam
10/23/2003WO2003087323A2 Biologic modulations with nanoparticles
10/23/2003WO2003087287A1 Targeted controlled delivery compositions activated by changes in ph or salt concentration
10/23/2003WO2003087220A2 Solid emulsions based on thermoplastic elastomers
10/23/2003WO2003087196A1 Thermogelling oligopeptide polymers
10/23/2003WO2003087189A1 Functionalized polymers and their biomedical and pharmaceutical uses
10/23/2003WO2003087180A2 New film coating
10/23/2003WO2003087174A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers
10/23/2003WO2003087164A1 Iron dextrin compounds for the treatment of iron deficiency anaemia
10/23/2003WO2003087159A2 Modulators of the notch signalling pathway and uses thereof in medical treatment
10/23/2003WO2003087108A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087097A1 Medicaments containing betamimetic drugs and a novel anticholinesterase drug
10/23/2003WO2003087049A2 Pharmaceutical combinations containing heterocyclic compounds and a novel anticholinergic agent
10/23/2003WO2003087040A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087021A2 Nanoparticle delivery systems and methods of use thereof
10/23/2003WO2003086526A1 Implantable pressure-activated micro-valve
10/23/2003WO2003086516A1 Therapeutic dry powder preparation
10/23/2003WO2003086471A2 Lyophilized and liquid preparations comprising a polysaccharide derivative of camptothecin
10/23/2003WO2003086469A1 Ethyl cellulose-containing veterinary sustained release injection
10/23/2003WO2003086468A1 Aqueous dispersible steryl ester compositions
10/23/2003WO2003086454A1 Antigen-loaded chitosan microparticles for oral vaccination
10/23/2003WO2003086443A1 Spray freeze dry of compositions for intranasal administration
10/23/2003WO2003086442A2 Ophthalmic, pharmaceutical and other healthcare preparations with naturally occuring plant compounds, extracts and derivatives
10/23/2003WO2003086436A1 Enteric fat absorption inhibitors contaiing plant extract and foods containing the same
10/23/2003WO2003086434A1 Drinking tea for treating dermatitis
10/23/2003WO2003086423A1 Low-dose potassium supplementation for the prevention and treatment of hypertension
10/23/2003WO2003086419A1 Antibiotic/benzoyl peroxide dispenser
10/23/2003WO2003086415A1 Method for inhibiting bone resorption with an alendronate and vitamin d formulation
10/23/2003WO2003086405A1 Solid dispersion composition
10/23/2003WO2003086399A1 Medicaments containing steroids and a novel anticholinesterase drug
10/23/2003WO2003086392A2 Process for preparing a finely self-emulsifiable pharmaceutical composition
10/23/2003WO2003086387A1 Stable tablets comprising simvastatin
10/23/2003WO2003086381A1 Ansamycin formulations and methods for producing and using same
10/23/2003WO2003086376A1 Patch and process for producing the same
10/23/2003WO2003086370A1 Transdermal patches having a siliconic adhesive matrix stabilized with methacrylic copolymers
10/23/2003WO2003086369A2 Stealthy polymeric biodegradable nanospheres and uses thereof
10/23/2003WO2003086368A1 Liquid compositions for soft sustained-release capsules and method for production thereof
10/23/2003WO2003086367A1 Low dose liquid entecavir formulations and use
10/23/2003WO2003086366A1 An improved modified release preparation
10/23/2003WO2003086365A1 Analgesical oral composition with controlled release of an opioid
10/23/2003WO2003086364A1 Sustained release pharmaceutical prepartations and methods for producing the same
10/23/2003WO2003086363A1 Drug-complex microparticles and methods of making/using same
10/23/2003WO2003086362A2 Method of stabilizing bupropion hydrochloride tablets
10/23/2003WO2003086361A1 Rapidly dispersing solid oral compositions
10/23/2003WO2003086360A1 Agent for producing a sensation of satiety and for weight loss
10/23/2003WO2003086359A1 Tea polyphenol buccal tablet for preventing and treating tooth decay and its preparing method
10/23/2003WO2003086358A1 Excipient for use in dry powder inhalation preparations
10/23/2003WO2003086357A1 Diphenhydramine tannate liquid and semi-solid compositions and methods of use
10/23/2003WO2003086356A1 Diphenhydramine tannate solid dose compositions and methods of use
10/23/2003WO2003086355A1 Novel polymorphs and pseudopolymorphs of risedronate sodium
10/23/2003WO2003086354A1 Nanoparticulate megestrol formulations
10/23/2003WO2003086353A1 Sustained release metoprolol formulations
10/23/2003WO2003086352A1 Pharmaceutical formulation comprising melatonin
10/23/2003WO2003086351A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
10/23/2003WO2003086350A1 Formoterol and mometasone aerosol formulations
10/23/2003WO2003086349A1 Formoterol and ciclesonide aerosol formulations
10/23/2003WO2003086348A1 Allergic dermatitis formulation and method of treatment
10/23/2003WO2003086347A1 Process for preparation of a sterile suspension of corticosteroid particles for the administration by inhalation
10/23/2003WO2003086346A1 Diphenhydramine tannate compositions and methods of use
10/23/2003WO2003086345A1 Process for loading a drug delivery device
10/23/2003WO2003086344A1 Antibiotic product, use and formulation thereof
10/23/2003WO2003086343A2 Fast disintegrating oral dosage forms
10/23/2003WO2003086332A1 Antimicrobial wash and carrier solutions, and uses thereof
10/23/2003WO2003086326A2 G-type peptides to ameliorate atherosclerosis
10/23/2003WO2003086321A2 Modified release minerals
10/23/2003WO2003086313A2 Methods for lightening skin and hair
10/23/2003WO2003086305A2 Biodegradable peg-based polymer formulations in ocular applications
10/23/2003WO2003086297A2 Multi-layer mucoadhesive drug delivery device with bursting release layer
10/23/2003WO2003086295A2 Process for preparing tannate liquid and semi-solid dosage forms
1 ... 2076 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 ... 2991